Shen Jianzhong, Seye Cheikh I, Wang Meifang, Weisman Gary A, Wilden Peter A, Sturek Michael
Department of Medical Pharmacology and Physiology, Center for Diabetes and Cardiovascular Health, University of Missouri-Columbia, School of Medicine, USA.
Mol Pharmacol. 2004 Nov;66(5):1265-74. doi: 10.1124/mol.104.002642. Epub 2004 Jul 27.
Previous work has shown up-regulation of a UTP-sensitive P2Y receptor in porcine coronary smooth muscle cells (CSMC) of organ-cultured arteries. However, the molecular identity and functional role of this putative receptor remained undefined. Here we report the cloning of the cDNA for this receptor that encodes an open reading frame for a protein of 373 amino acids with the highest homology to the human P2Y(2) receptor (84%). Heterologous expression of this receptor in 1321N1 cells revealed a novel pharmacology in that UTP and ITP were full agonists and UTP was more potent and efficacious than ATP for increasing intracellular [Ca(2+)] and extracellular signal-regulated kinase phosphorylation. Stimulation of subcultured CSMC with UTP, ITP, or ATP induced a concentration-dependent increase in cellular DNA content, protein synthesis, cell number, and proliferating cell nuclear antigen expression, indicating a mitogenic role for P2Y(2) receptors. This was supported by the finding that the treatment of CSMC with antisense oligonucleotides to the cloned cDNA sequence significantly inhibited UTP- and ATP-induced DNA and protein synthesis. In addition, reverse transcription-polymerase chain reaction analysis showed that P2Y(2) receptor mRNA was dramatically increased in cells of organ-cultured arteries compared with freshly harvested arteries, whereas the P2Y(6) receptor mRNA level was unchanged, and the P2Y(4) receptor mRNA was undetectable. This P2Y(2) subtype-specific up-regulation was confirmed in cells of coronary arteries stented in vivo. In conclusion, we have cloned the porcine P2Y(2) receptor with novel pharmacology and demonstrated that this receptor is up-regulated in CSMC of in vitro organ cultures or in vivo stented coronary arteries to mediate the mitogenic effects of nucleotides.
先前的研究表明,在器官培养动脉的猪冠状动脉平滑肌细胞(CSMC)中,一种对UTP敏感的P2Y受体上调。然而,这种假定受体的分子身份和功能作用仍不明确。在此,我们报告了该受体的cDNA克隆,其编码一个由373个氨基酸组成的开放阅读框,与人P2Y(2)受体的同源性最高(84%)。该受体在1321N1细胞中的异源表达揭示了一种新的药理学特性,即UTP和ITP是完全激动剂,并且在增加细胞内[Ca(2+)]和细胞外信号调节激酶磷酸化方面,UTP比ATP更有效且效力更强。用UTP、ITP或ATP刺激传代培养的CSMC会导致细胞DNA含量、蛋白质合成、细胞数量和增殖细胞核抗原表达呈浓度依赖性增加,表明P2Y(2)受体具有促有丝分裂作用。用针对克隆cDNA序列的反义寡核苷酸处理CSMC可显著抑制UTP和ATP诱导的DNA和蛋白质合成,这一发现支持了上述结论。此外,逆转录-聚合酶链反应分析表明,与新鲜收获的动脉相比,器官培养动脉细胞中的P2Y(2)受体mRNA显著增加,而P2Y(6)受体mRNA水平未改变,且未检测到P2Y(4)受体mRNA。这种P2Y(2)亚型特异性上调在体内植入支架的冠状动脉细胞中得到证实。总之,我们克隆了具有新药理学特性的猪P2Y(2)受体,并证明该受体在体外器官培养或体内植入支架的冠状动脉的CSMC中上调,以介导核苷酸的促有丝分裂作用。